By Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, reports a study in Urology Practice.
Genetic testing for prostate cancer increases after introduction of point-of-care program
3D render of a medical background with DNA strands
Comments